150
Participants
Start Date
June 30, 2005
Study Completion Date
March 31, 2006
Fibrin sealant (FS2)
Alband Medical Center, Albany
Millarad Fillmore Hospital, SUNY, Buffalo
UVA Health System, Charlottesville
Vascular and Transplant Specialists, Norfolk
Baptist Medical Center, Jacksonville
Memorial Hospital, Jacksonville
Jackson Memorial Hospital, Miami
Vanderbilt Univ Medical Center, Nashville
Jobst Vascular Center, Toledo
Iowa Heart Center, Des Moines
Southern Illinois University School of Medicine, Springfield
Univ of Mass Medical Center, Worcester
Hackensack Medical Center, Hackensack
Aberdeen Royal Infirmary, Aberdeen
Birmingham Heartlands Hospital, Birmingham
Royal Infirmary of Edinburgh, Edinburgh
Hull Royal Infirmary, Hull
Collaborators (1)
OMRIX Biopharmaceuticals
INDUSTRY
Ethicon, Inc.
INDUSTRY